跳至主要内容
临床试验/NCT02260206
NCT02260206已完成4 期

Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Following Catheter Ablation of Atrial Fibrillation

Yong Seog Oh1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
recurrence of atrial arrhythimia

研究概览

简要总结

The effects colchicine administration for acute pericardial effusion after radiofrequency catheter ablation (RFCA) of atrial fibrillation on the recurrences of arrhythmia.

详细描述

RFCA was started as a rhythm control of atrial fibrillation about 10 years before and the superiority of RFCA to medical treatment has been continuously reporting, so RFCA is globally performed nowadays. Acute pericardial effusion could occur during RFCA as complication, that might be developed to cardiac tamponade needed immediate pericardiocentesis. The inflammation developed after pericardiocentesis might be associated with the recurrences of atrial fibrillation, it could be presumed by the frequent occurrence of atrial fibrillation after open-heart surgery. The inflammation can be suppressed by administration of colchicine and the effects of colchicine have been proven to decrease the development of atrial fibrillation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients needed to pericardiocentesis during RFCA for paroxysmal or persistent atrial fibrillation.

排除标准

  • Hypersensitivity on Colchicine
  • The existence of intra-cardiac thrombus on trans-esophageal echocardiography
  • Pregnancy

研究组 & 干预措施

Colchicine

Experimental

Impact of Colchicine therapy on arrhythmia Recurrence after Acute Pericardial Effusion following Catheter Ablation of Atrial Fibrillation

干预措施: Colchicine (Drug)

结局指标

主要结局

recurrence of atrial arrhythimia

时间窗: 1 year after colchicines administration

Assessment of the recurrence of atrial arrhythimia 1 year after colchicines administration

次要结局

  • recurrence of atrial arrhythimia(3 year after colchicines administration)

研究者

发起方
Yong Seog Oh
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yong Seog Oh

MD

Seoul St. Mary's Hospital

研究点 (1)

Loading locations...

相似试验